ArthroCare Corp (OTC:ARTC) has announced that it participate at the JP Morgan 28th Annual Healthcare Conference on Monday, January 11. The company will be represented by President and CEO David Fitzgerald. Mr. Fitzgerald is scheduled to begin his presentation at 4:30 pm PT that afternoon. A webcast of the presentation will be broadcasted live on the company’s website, http://www.arhtrocare.com/. The webcast will remain on the site for instant replay for thirty days following the end of the event.
Penny Stock Professor, a leading financial publication, is pleased to alert investors of stocks on the move. Sign Up for our Free Penny Stock Picks.
ArthroCare Corporation (ArthroCare) is a medical device company that develops, manufactures and markets surgical products, many of which are based on its Coblation technology. The Company’s business is divided into three business units: Sports Medicine, Ear Nose and Throat (ENT), and Spine. Each of the Sports Medicine, ENT and Spine business units market and sell their products in two principal geographic markets: Americas (North and South America) and International (all other geographies). Many of its products are based on its Coblation technology, which uses bipolar radiofrequency energy to create a plasma field to remove and shape soft tissues, such as cartilage and tendons. ArthroCare’s bipolar Coblation devices also include both an active and return electrode at the tip. Its Coblation-based systems consist of a controller unit with accessories and an assortment of sterile, single-use disposable devices that are engineered to address specific types of procedures.
Follow us on Twitter: http://www.twitter.com/pennystockspro
Sign up for the free Penny Stock Professor newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
About Us
Penny Stock Professor is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.
